That he was never considered for the Nobel Prize is one of medicine’s great injustices.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback